These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

185 related items for PubMed ID: 23574733

  • 21. Appropriate Implantable Defibrillator Therapy in Adults With Hypertrophic Cardiomyopathy.
    Thavikulwat AC, Tomson TT, Knight BP, Bonow RO, Choudhury L.
    J Cardiovasc Electrophysiol; 2016 Aug; 27(8):953-60. PubMed ID: 27138377
    [Abstract] [Full Text] [Related]

  • 22. Use of myocardial scar characterization to predict ventricular arrhythmia in cardiac resynchronization therapy.
    Fernández-Armenta J, Berruezo A, Mont L, Sitges M, Andreu D, Silva E, Ortiz-Pérez JT, Tolosana JM, de Caralt TM, Perea RJ, Calvo N, Trucco E, Borràs R, Matas M, Brugada J.
    Europace; 2012 Nov; 14(11):1578-86. PubMed ID: 22562658
    [Abstract] [Full Text] [Related]

  • 23. Prophylactic implantable cardioverter defibrillator treatment in patients with end-stage heart failure awaiting heart transplantation.
    Fröhlich GM, Holzmeister J, Hübler M, Hübler S, Wolfrum M, Enseleit F, Seifert B, Hürlimann D, Lehmkuhl HB, Noll G, Steffel J, Falk V, Lüscher TF, Hetzer R, Ruschitzka F.
    Heart; 2013 Aug; 99(16):1158-65. PubMed ID: 23813845
    [Abstract] [Full Text] [Related]

  • 24. Outcomes After Implantable Cardioverter-Defibrillator Generator Replacement for Primary Prevention of Sudden Cardiac Death.
    Madhavan M, Waks JW, Friedman PA, Kramer DB, Buxton AE, Noseworthy PA, Mehta RA, Hodge DO, Higgins AY, Webster TL, Witt CM, Cha YM, Gersh BJ.
    Circ Arrhythm Electrophysiol; 2016 Mar; 9(3):e003283. PubMed ID: 26921377
    [Abstract] [Full Text] [Related]

  • 25. CMR imaging predicts death and other adverse events in suspected cardiac sarcoidosis.
    Greulich S, Deluigi CC, Gloekler S, Wahl A, Zürn C, Kramer U, Nothnagel D, Bültel H, Schumm J, Grün S, Ong P, Wagner A, Schneider S, Nassenstein K, Gawaz M, Sechtem U, Bruder O, Mahrholdt H.
    JACC Cardiovasc Imaging; 2013 Apr; 6(4):501-11. PubMed ID: 23498675
    [Abstract] [Full Text] [Related]

  • 26. Impact of Chronic Total Coronary Occlusion on Recurrence of Ventricular Arrhythmias in Ischemic Secondary Prevention Implantable Cardioverter-Defibrillator Recipients (VACTO Secondary Study): Insights From Coronary Angiogram and Electrogram Analysis.
    Nombela-Franco L, Iannaccone M, Anguera I, Amat-Santos IJ, Sanchez-Garcia M, Bautista D, Calvelo MN, Di Marco A, Moretti C, Pozzi R, Scaglione M, Cañadas V, Sandin-Fuentes M, Arenal A, Bagur R, Perez-Castellano N, Fernandez-Perez C, Gaita F, Macaya C, Escaned J, Fernández-Lozano I.
    JACC Cardiovasc Interv; 2017 May 08; 10(9):879-888. PubMed ID: 28473110
    [Abstract] [Full Text] [Related]

  • 27. Infarct tissue characterization in implantable cardioverter-defibrillator recipients for primary versus secondary prevention following myocardial infarction: a study with contrast-enhancement cardiovascular magnetic resonance imaging.
    Olimulder MA, Kraaier K, Galjee MA, Scholten MF, van Es J, Wagenaar LJ, van der Palen J, von Birgelen C.
    Int J Cardiovasc Imaging; 2013 Jan 08; 29(1):169-76. PubMed ID: 22684301
    [Abstract] [Full Text] [Related]

  • 28. The amount of late gadolinium enhancement outperforms current guideline-recommended criteria in the identification of patients with hypertrophic cardiomyopathy at risk of sudden cardiac death.
    Freitas P, Ferreira AM, Arteaga-Fernández E, de Oliveira Antunes M, Mesquita J, Abecasis J, Marques H, Saraiva C, Matos DN, Rodrigues R, Cardim N, Mady C, Rochitte CE.
    J Cardiovasc Magn Reson; 2019 Aug 15; 21(1):50. PubMed ID: 31412875
    [Abstract] [Full Text] [Related]

  • 29. Prediction of life-threatening arrhythmic events in patients with chronic myocardial infarction by contrast-enhanced CMR.
    Boyé P, Abdel-Aty H, Zacharzowsky U, Bohl S, Schwenke C, van der Geest RJ, Dietz R, Schirdewan A, Schulz-Menger J.
    JACC Cardiovasc Imaging; 2011 Aug 15; 4(8):871-9. PubMed ID: 21835379
    [Abstract] [Full Text] [Related]

  • 30. Scar extent as a predictive factor of ventricular tachycardia cycle length after myocardial infarction: implications for implantable cardioverter-defibrillator programming optimization.
    Alexandre J, Saloux E, Lebon A, Dugué AE, Lemaitre A, Roule V, Labombarda F, Champ-Rigot L, Gomes S, Pellissier A, Scanu P, Milliez P.
    Europace; 2014 Feb 15; 16(2):220-6. PubMed ID: 24186956
    [Abstract] [Full Text] [Related]

  • 31. Scar Characterization to Predict Life-Threatening Arrhythmic Events and Sudden Cardiac Death in Patients With Cardiac Resynchronization Therapy: The GAUDI-CRT Study.
    Acosta J, Fernández-Armenta J, Borràs R, Anguera I, Bisbal F, Martí-Almor J, Tolosana JM, Penela D, Andreu D, Soto-Iglesias D, Evertz R, Matiello M, Alonso C, Villuendas R, de Caralt TM, Perea RJ, Ortiz JT, Bosch X, Serra L, Planes X, Greiser A, Ekinci O, Lasalvia L, Mont L, Berruezo A.
    JACC Cardiovasc Imaging; 2018 Apr 15; 11(4):561-572. PubMed ID: 28780194
    [Abstract] [Full Text] [Related]

  • 32. Long-term follow-up of implantable cardioverter-defibrillators in adult congenital heart disease patients: indications and outcomes.
    Santharam S, Hudsmith L, Thorne S, Clift P, Marshall H, De Bono J.
    Europace; 2017 Mar 01; 19(3):407-413. PubMed ID: 27234868
    [Abstract] [Full Text] [Related]

  • 33. Clinical Outcomes of Single- versus Dual-Chamber Implantable Cardioverter Defibrillators: Lessons from the Israeli ICD Registry.
    Konstantino Y, Haim M, Boxer J, Goldenberg I, Feldman A, Michowitz Y, Glikson M, Suleiman M, Israeli Working Group on Pacing and Electrophysiology.
    J Cardiovasc Electrophysiol; 2016 Jun 01; 27(6):718-23. PubMed ID: 26852908
    [Abstract] [Full Text] [Related]

  • 34. Early echocardiographic deformation analysis for the prediction of sudden cardiac death and life-threatening arrhythmias after myocardial infarction.
    Ersbøll M, Valeur N, Andersen MJ, Mogensen UM, Vinther M, Svendsen JH, Møller JE, Kisslo J, Velazquez EJ, Hassager C, Søgaard P, Køber L.
    JACC Cardiovasc Imaging; 2013 Aug 01; 6(8):851-60. PubMed ID: 23850252
    [Abstract] [Full Text] [Related]

  • 35. Dual- vs. single-chamber defibrillators for primary prevention of sudden cardiac death: long-term follow-up of the Défibrillateur Automatique Implantable-Prévention Primaire registry.
    Defaye P, Boveda S, Klug D, Beganton F, Piot O, Narayanan K, Périer MC, Gras D, Fauchier L, Bordachar P, Algalarrondo V, Babuty D, Deharo JC, Leclercq C, Marijon E, Sadoul N, DAI-PP Investigators.
    Europace; 2017 Sep 01; 19(9):1478-1484. PubMed ID: 28340096
    [Abstract] [Full Text] [Related]

  • 36. Scar channels in cardiac magnetic resonance to predict appropriate therapies in primary prevention.
    Sánchez-Somonte P, Quinto L, Garre P, Zaraket F, Alarcón F, Borràs R, Caixal G, Vázquez S, Prat S, Ortiz-Perez JT, Perea RJ, Guasch E, Tolosana JM, Berruezo A, Arbelo E, Sitges M, Mont L, Roca-Luque I.
    Heart Rhythm; 2021 Aug 01; 18(8):1336-1343. PubMed ID: 33892202
    [Abstract] [Full Text] [Related]

  • 37. Sex differences in implantable cardioverter-defibrillator implantation indications and outcomes: lessons from the Nationwide Israeli-ICD Registry.
    Amit G, Suleiman M, Konstantino Y, Luria D, Kazatsker M, Chetboun I, Haim M, Gavrielov-Yusim N, Goldenberg I, Glikson M, Israeli Working Group on Pacing and Electrophysiology.
    Europace; 2014 Aug 01; 16(8):1175-80. PubMed ID: 24554524
    [Abstract] [Full Text] [Related]

  • 38. Low Prevalence of Inappropriate Shocks in Patients With Inherited Arrhythmia Syndromes With the Subcutaneous Implantable Defibrillator Single Center Experience and Long-Term Follow-Up.
    Rudic B, Tülümen E, Berlin V, Röger S, Stach K, Liebe V, El-Battrawy I, Dösch C, Papavassiliu T, Akin I, Borggrefe M, Kuschyk J.
    J Am Heart Assoc; 2017 Oct 17; 6(10):. PubMed ID: 29042423
    [Abstract] [Full Text] [Related]

  • 39. Influence of time between last myocardial infarction and prophylactic implantable defibrillator implant on device detections and therapies. "Routine Practice" data from the SEARCH MI registry.
    Boriani G, Botto G, Lunati M, Proclemer A, Schmidt B, Erdogan A, Rauhe W, Biffi M, Santi E, Becker D, Messier M, Santini M.
    BMC Cardiovasc Disord; 2012 Sep 11; 12():72. PubMed ID: 22966862
    [Abstract] [Full Text] [Related]

  • 40. Mean entropy predicts implantable cardioverter-defibrillator therapy using cardiac magnetic resonance texture analysis of scar heterogeneity.
    Gould J, Porter B, Claridge S, Chen Z, Sieniewicz BJ, Sidhu BS, Niederer S, Bishop MJ, Murgatroyd F, Ganeshan B, Carr-White G, Razavi R, Chiribiri A, Rinaldi CA.
    Heart Rhythm; 2019 Aug 11; 16(8):1242-1250. PubMed ID: 30849532
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.